Once in the lymph node, CD103+ cDC1 activate naïve CD8+ T cells with evidence suggesting that tumor antigens are also simultaneously transferred to the lymphoid resident CD8+ cDC1 and CD11b+ cDC2 [41,49,50]. The gene discussed is CD8A; the disease is neoplasm.